This case article explores an experiment in the open innovation applied to the scientific research on the Type 1 diabetes at the Harvard Medical School. In the standard research process, one research team normally carries through each stage of the process -from generating the notion to raising money to carrying out the research and publishing the results.
Harvard Catalyst, a pan-Harvard bureau with a mission to accelerate biomedical research from the lab to patients' bedsides, changed the traditional grant proposal process as an experiment in bringing greater openness into every phase of research. Participation was successfully extended to nontraditional performers. Ultimately, research pathways and 150 new hypotheses were proposed. Teams were encouraged to propose projects on the 12 most promising of these; seven teams are carrying out the research, now. The Harvard Catalyst encounter implies that open innovation principles may be embraced within a well- experienced and established invention-driven organization.
PUBLICATION DATE: April 01, 2013 PRODUCT #: SMR446-PDF-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
A Currency We Can Call Our Own: Populism, Banking Crises, and Exchange Rate Crises in Argentina, 1946-2002
paREDI: Regional Economic Development and Strategic Planning
Balancing Stakeholder Interests and Corporate Values: A Cummins Strategic Decision.
Fiat-Chrysler Alliance: Launching the Cinquecento in North America
Grolsch: Growing Globally
Internet Securities, Inc.: Path to Sustainability
Mittal Steel in 2006: Changing the Steel Game
Orascom Telecom: Risks of Internationalization
Competing with Social Networks: Designing Social Strategy
Shanzhai (“Bandit”) Mobile Phone Companies: The Guerrilla Warfare of Product Development and Supply Chain Management
